Major Zymeworks Shareholder Liquidates Seventy Million Dollars Following Massive Annual Stock Surge
A prominent institutional investor has executed a significant divestment from Zymeworks, offloading approximately $70 million in equity after the biotechnology company witnessed
by 
Josh Weiner
Josh Weiner